Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone

INTRODUCTION: Twenty-five percent of stage II colon cancer (CC) patients relapse within 5 years due to minimal residual disease (MRD) not eliminated by surgery. We hypothesise that subtypes of MRD, defined by circulating tumour cells (CTCs) and bone marrow micrometastasis (mM), have different types...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Nigel P, Aedo, Socrates, Villalon, Ricardo, Albarran, Vidal, Orrego, Shenda, Guzman, Eghon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652547/
https://www.ncbi.nlm.nih.gov/pubmed/33209110
http://dx.doi.org/10.3332/ecancer.2020.1119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652547/
https://www.ncbi.nlm.nih.gov/pubmed/33209110
http://dx.doi.org/10.3332/ecancer.2020.1119

Ejemplares similares